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renal ET pathway. To test this hypothesis, we measured urinary ET-1
excretion, inner medullary (IM) ET receptor (ETR) expression from
mice on a NSD or 7 day high salt diet (7DHS) and the response of ET-
1 mediated epithelial sodium channel (ENaC) activity in ﬂox and
CDNOS1KO mice. ET-1 excretion was similar between NSD ﬂox
and CDNOS1KO mice (0.14 ± 0.02 and 0.17 ± 0.06 pg/day, n = 10)
and signiﬁcantly increased similarly after a 7DHS (0.60 ± 0.1 and
0.60 ± 0.08 pg/day). IM ETR expression was similar between the
mice on a NSD (~40% ETA, ~60% ETB receptors) and similarly shifted
to ~95% ETB expression on a 7DHS. Basal CD ENaC open probability
(Po) was similar (ﬂox: 0.3 ± 0.08 CDNOS1KO: 0.3 ± 0.05). Acute ET-
1 treatment signiﬁcantly reduced ENaC Po from ﬂox mice but not
CDNOS1KO mice compared to basal (ﬂox 0.1 ± 0.03 and CDNOS1KO
0.3 ± 0.05, n = 6 animals P b 0.05). In conclusion, CD NOS1 appears
not to regulate renal ET-1 production or ETR expression. However,
the mechanism of ET-1 inhibition of CD ENaC is via NOS1. We pro-
pose that the salt-dependent increase in BP and Na retention ob-
served in CDNOS1KO mice is mediated by the loss of ET signaling in
the CD.
doi:10.1016/j.lfs.2013.12.076
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Renal ischemia/reperfusion injury (I/R) is the most frequent
cause of acute kidney injury. It had been reported that endothelin-1
deletion from endothelial cells attenuates I/R injury. Heparanase
is an enzyme that degrades endothelial surface layer and induces
endothelial injury. The association between heparanase and ET-1 in
kidney I/R is still unclear. We induced hypoxic condition for 30 min
in a MS-1 endothelial cell culture using a hypoxic bag. We extracted
RNA and quantiﬁed pre-pro-ET1, heparanase, endothelial nitrite
oxide synthase (eNOS) and ICAM-1. To examine heparanase con-
tribution in I/R, we performed a kidney I/R injury model in black-six
mice (n = 7) using renal pedicle clamping for 30 min and sacriﬁced
the mice in 1, 3 and 24 h after operation. Sham-operation procedure
(SO, n = 5) was used as control. PAS was used to quantify tubular
injury score. Serum creatinine was quantiﬁed from orbital venous.
We did immunostaining for heparanase and double glycocalyx-von
Willebrand factor to elucidate the contribution of heparanase in the
early step of ischemic acute kidney injury. Western-blot was used
to analyze eNOS expression. Ischemia induced a signiﬁcant increase
of pre-proET-1 and heparanase mRNA expression that was associat-
ed with ICAM-1 elevation and eNOS reduction. In-vivo, we found
elevation of heparanase mRNA expression in the early stage of I/R
injury (1, 3 and 24 h). This is associated with increase of tubular
injury score, creatinine serum level and eNOS reduction. In a further
analysis, EC derived ET-1 signiﬁcantly reduced heparanase mRNA
(p b 0.05) expression after kidney I/R injury. In this study, we suggested
that heparanase might contribute to the ET-1 effect in inducing endo-
thelial injury in hypoxic and kidney I/R condition.
doi:10.1016/j.lfs.2013.12.077
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Kidney ﬁbrosis is a ﬁnal pathway of chronic kidney disease (CKD)
and characterized by myoﬁbroblast formation from renal interstitial
cells. The clear mechanism of how endothelin-1 and its receptors
involved in CKD cause interstitial cell proliferation is still unknown.
We performed unilateral ureteral obstruction (UUO) in vascular
endothelial endothelin-1 knock-out (VEETKO, n = 7) and WT mice
(n = 7), which were then sacriﬁced in days 3 and 14. We observed
renal ﬁbrosis, the myoﬁbroblast area, and the capillary number using
Sirius Red, α-SMA, and CD31 immunostaining. Double α-SMA and
PDGFRβ staining and quantiﬁcation were done to examine intersti-
tial cell expansion. Renal blood ﬂow was observed and quantiﬁed by
laser Doppler imaging. Western blot was done to examine α-SMA,
PDGFRβ and TGFβ1 expression. Kidney ET-1 system was measured
using ELISA and real time PCR. Double α-SMA and ETAR immuno-
staining was done to elucidate ETAR in myoﬁbroblast cells. We found
signiﬁcantly lower ﬁbrosis, myoﬁbroblast area, and TGFβ1 expres-
sion (p b 0.05) in VEETKO mice compare to WT mice. Kidney ET1 and
pre-pro ET-1 mRNA levels increased after UUO, however were
signiﬁcantly lower in VEETKO mice. VEETKO mice also had sig-
niﬁcantly lower interstitial cell expansion and myoﬁbroblast area
compared to WT mice. EC derived ET-1 deletion also improved renal
blood ﬂow and capillary number (p b 0.05) after UUO. We observed
ETAR expression in the myoﬁbroblast area and is colocalized with
PDGFRβ. EC derived ET-1 deletion attenuates kidney ﬁbrosis via
preserving the capillary and reducing interstitial cell expansion and
myoﬁbroblast formation. ETAR from interstitial cells may induce
proliferation and myoﬁbroblast formation. Targeting the ET-1 and
ETAR axes in EC and interstitial cell may give the best approach to
treat kidney ﬁbrosis.
doi:10.1016/j.lfs.2013.12.078
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Sickle cell nephropathy (SCN) is a chronic manifestation of sickle
cell disease (SCD). We previously found that reactive oxygen species
(ROS) were elevated in the glomeruli from SCD mice. Importantly,
treatment with ABT-627, a selective ET-A receptor antagonist, re-
duced glomerular ROS production in SCD mice to levels observed in
controls. Because SCN is thought to progress secondary to repeated
occlusions in the microvasculature, we hypothesized that hypoxia
stimulates the production of glomerular ET-1, causing deleterious
effects through over-production of ROS. To directly test if ET-1 is
increased in response to hypoxia in unaffected mice, we exposed
vascular endothelial ET-1 knockout (VEET) mice and ﬂoxed controls
to normoxia or 3 h of hypoxia (8% O2). In response to hypoxia, ﬂoxed
mice had signiﬁcant increases in glomerular ET-1 mRNA while there
was no response to hypoxia in the VEETmice, indicating that hypoxia
stimulates endothelial-derived glomerular ET-1 (ﬂoxed hypoxia:
2.1 ± 0.2, ﬂoxed normoxia: 1.1 ± 0.2, VEET hypoxia: 0.7 ± 0.1, VEET
normoxia: 0.8 ± 0.3 fold change, p b 0.01, n = 6/group). To deter-
mine the inﬂuence of chronically elevated ET-1 on glomerular ROS
production, C57BL/6J mice were treated with saline or ET-1 (2 weeks
@2 pg/kg/day) via a miniosmotic pump. Mice treated with ET-1
demonstrated signiﬁcant increases in stimulated ROS production
compared to saline controls (5452 ± 655 vs. 2177 ± 359 luminescence/
protein∗min, p b 0.01, n = 5–6). These data reveal that hypoxia leads
to upregulation of endothelial-derived glomerular ET-1 and that chronic
elevations in ET-1, similar to what is seen in SCD, increase ROS pro-
duction in the glomeruli. Taken together, these data identify a novel
mechanism by which hypoxia stimulates the upregulation of ET-1 in
glomerular endothelial cells and promotes glomerular ROS production.
doi:10.1016/j.lfs.2013.12.079
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Hypertension plays a critical role in the progression of chronic
kidney disease (CKD). Recent studies have shown that besides the
inappropriately activated renin–angiotensin system (RAS), enhanced
intrarenal activity of the endothelin (ET) system via activation of ET
receptor type A (ETA) contributes to the pathophysiology of hyper-
tension and progression of CKD. We therefore evaluated whether
addition of selective ETA receptor blockade to the standard RAS
blockade will exhibit additional beneﬁcial effects on the progression
of CKD. Ren-2 transgenic rats (TGR) underwent 5/6 renal ablation
(5/6 NX) serving as model of CKD. A combination of angiotensin-
converting enzyme inhibitor (trandolapril, 6 mg/l drinking water) and
angiotensin II receptor blocker (losartan, 100 mg/l drinking water)
was used. ETA receptor blocker (atrasentan, 5 mg·kg−1·day−1) was
employed with the combination of RAS blockade. The follow-up period
was 44 weeks after 5/6 NX. The following parameters were evaluated:
survival rate, systolic blood pressure (SBP), proteinuria and renal glo-
merular damage. Both therapeutical regimes improved survival rate,
however the efﬁciency of isolated RAS blockade considerably decreased
at 36 weeks after 5/6 NX (ﬁnal survival rate was 65%). The combined
RAS and ETA receptor blockade exhibited a ﬁnal survival rate of 91%,
which was signiﬁcantly better as compared with isolated RAS in-
hibition, even if there were no signiﬁcant differences in SBP among the
experimental groups. In addition, the RAS and ETA receptor blockade
further reduced proteinuria and renal glomerular damage. Our data
show that a combined RAS and ETA receptor blockade exhibited
additional beneﬁcial effects on the progression of CKD in 5/6 NX TGR as
compared with isolated RAS inhibition.
doi:10.1016/j.lfs.2013.12.080
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Septic acute kidney injury (AKI) remains associated with high
mortality rate, partially, because of the poor understanding of its
(patho)physiology. Endothelin-1 (ET-1), which is produced and is
secreted from vascular endothelium, plays important roles on renal
hemodynamics via autocrine/paracrine and, possibly, hormonal mech-
anisms. Previous studies have demonstrated that either selective or
non-selective endothelin antagonists attenuate the hemodynamic
changes in experimental sepsis models. Thus, we investigated the role
of endothelial cell-derived ET-1 on the severity of lipopolysaccharide
(LPS)-induced AKI by using endothelial cell-speciﬁc ET-1 knock-out
mice (VEETKO). The renal microcirculation dynamics was observed by
intravital 2-photon laser microscopy. LPS (from Escherichia coli O55:B5,
5 mg/kg, i.p.) increased leukocyte attachment in the capillary walls,
whereas there was maintained plasma ﬂow in the peritubular capillar-
ies in VEETKO. The urine ﬂow rate was reduced to half in VEETKO
compared with that in normal (LPS-untreated) C57B6 mice, while the
blood urea nitrogen level was still at normal level in VEETKO (22.8 ±
0.2 mg/dL vs. 52.9 ± 12.7 mg/dL in C57B6) at 24 h after LPS injection.
Fluid resuscitation (1.5 mL of saline, s.c., at 6 and 14 h after LPS)
normalized the LPS-induced increase in leukocyte attachment and the
decrease in urine ﬂow rate in VEETKO, but the effects were partial in
C57B6 mice. These results suggest that VEETKO kidney is less sensitive
against endotoxemia than the kidney of C57B6mice, and that leukocyte
attachment and reduction of urine ﬂow in VEETKO may be due to the
decrease in blood pressure by endotoxemia in combination with the
lack of ET-1.
doi:10.1016/j.lfs.2013.12.081
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